本页面由Tiger Trade Technology Pte. Ltd.提供服务

Summit Therapeutics PLC

15.52
-1.6100-9.40%
盘后:15.530.0100+0.06%16:14 EDT
成交量:710.16万
成交额:1.12亿
市值:123.81亿
市盈率:-13.89
高:16.79
开:16.79
低:15.47
收:17.13
52周最高:29.23
52周最低:12.07
股本:7.98亿
流通股本:1.54亿
量比:1.17
换手率:4.60%
股息:- -
股息率:- -
每股收益(TTM):-1.1177
每股收益(LYR):-1.4439
净资产收益率:-192.50%
总资产收益率:-101.61%
市净率:19.65
市盈率(LYR):-10.75

数据加载中...

2019/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/18

SEC问询函

[Cover]Correspondence
2019/06/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/22

非美公司披露报告

General statement of acquisition of beneficial ownership
2019/01/18

非美公司披露报告

Notice of Exempt Offering of Securities, item 06b
2019/01/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/11

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]